Transposagen Biophamaceuticals
2003
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Grant
LATEST DEAL TYPE
$4.3M
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of animal models, cell lines, stem cells, research tools and technologies to improve drug discovery and development research. The company is biotechnology based and provides genetically modified rat models to pharmaceutical and biotechnology companies, academic laboratories and the National Institutes of Health.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 535 West Second Street
- Suite L102
- Lexington, KY 40508
- United States
+1 (859) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Transposagen Biophamaceuticals’s full profile, request a free trial.
Transposagen Biophamaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 21-Jun-2013 | $4.3M | 00.000 | Completed | Generating Revenue | |
| 3. Angel (individual) | 18-Jul-2012 | 00000 | 00.000 | Completed | Generating Revenue | |
| 2. Angel (individual) | 20-Dec-2011 | $725K | $725K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
Transposagen Biophamaceuticals Competitors (14)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Caribou Biosciences | Venture Capital-Backed | Berkeley, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 | Corporation | Seoul, South Korea | 00 | |||
| 000000 00000000000 | Formerly VC-backed | Zug, Switzerland | 000 | 00000 | 00000000000 | 00000 |
| 00000000 | Venture Capital-Backed | Redwood City, CA | 00 | 00000 | 00000000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Menlo Park, CA | 000 | 00000 | 000000&0 | 00000 |
Transposagen Biophamaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 |
Transposagen Biophamaceuticals Executive Team (1)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Eric Ostertag Ph.D | Chief Executive Officer & President |